Phibro Animal Health Co. (NASDAQ:PAHC) Stake Reduced by WINTON GROUP Ltd

WINTON GROUP Ltd trimmed its stake in Phibro Animal Health Co. (NASDAQ:PAHCFree Report) by 2.1% during the second quarter, according to its most recent disclosure with the SEC. The fund owned 66,654 shares of the company’s stock after selling 1,403 shares during the quarter. WINTON GROUP Ltd’s holdings in Phibro Animal Health were worth $1,118,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently modified their holdings of the company. CWM LLC boosted its stake in Phibro Animal Health by 89.8% during the 2nd quarter. CWM LLC now owns 2,188 shares of the company’s stock valued at $37,000 after purchasing an additional 1,035 shares during the period. Fidelis Capital Partners LLC bought a new stake in shares of Phibro Animal Health during the first quarter valued at approximately $46,000. China Universal Asset Management Co. Ltd. boosted its position in shares of Phibro Animal Health by 65.0% during the first quarter. China Universal Asset Management Co. Ltd. now owns 3,888 shares of the company’s stock worth $50,000 after buying an additional 1,531 shares during the period. Quest Partners LLC bought a new position in Phibro Animal Health in the 4th quarter worth approximately $56,000. Finally, Summit Securities Group LLC acquired a new stake in Phibro Animal Health in the 2nd quarter valued at approximately $83,000. Institutional investors and hedge funds own 99.34% of the company’s stock.

Wall Street Analyst Weigh In

PAHC has been the subject of several recent analyst reports. Bank of America increased their price target on Phibro Animal Health from $13.00 to $15.00 and gave the stock an “underperform” rating in a research note on Friday, August 30th. JPMorgan Chase & Co. started coverage on shares of Phibro Animal Health in a research report on Tuesday, September 10th. They issued a “neutral” rating and a $22.00 target price for the company. Three investment analysts have rated the stock with a sell rating, two have assigned a hold rating and one has issued a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $15.00.

Get Our Latest Analysis on Phibro Animal Health

Phibro Animal Health Trading Up 3.7 %

Shares of PAHC stock opened at $21.99 on Monday. The stock has a 50-day simple moving average of $18.91 and a 200 day simple moving average of $16.62. The stock has a market capitalization of $890.60 million, a P/E ratio of 68.72, a P/E/G ratio of 1.60 and a beta of 0.52. Phibro Animal Health Co. has a fifty-two week low of $9.40 and a fifty-two week high of $22.31. The company has a quick ratio of 1.64, a current ratio of 2.94 and a debt-to-equity ratio of 1.79.

Phibro Animal Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, September 25th. Investors of record on Wednesday, September 4th will be issued a $0.12 dividend. The ex-dividend date of this dividend is Wednesday, September 4th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 2.18%. Phibro Animal Health’s payout ratio is currently 150.00%.

Insider Activity at Phibro Animal Health

In other Phibro Animal Health news, Director E Thomas Corcoran purchased 5,000 shares of the firm’s stock in a transaction on Wednesday, September 4th. The shares were purchased at an average price of $20.02 per share, for a total transaction of $100,100.00. Following the completion of the transaction, the director now owns 25,000 shares in the company, valued at approximately $500,500. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 50.06% of the company’s stock.

About Phibro Animal Health

(Free Report)

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.

See Also

Want to see what other hedge funds are holding PAHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Phibro Animal Health Co. (NASDAQ:PAHCFree Report).

Institutional Ownership by Quarter for Phibro Animal Health (NASDAQ:PAHC)

Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.